Clinical Testing News and Research

RSS

Texas A&M chemists focus on searching for drugs to treat COVID-19

In the wake of the novel coronavirus pandemic, Texas A&M University chemist Wenshe Ray Liu and his research team have focused their lab solely on searching for drugs to treat COVID-19.

6 Apr 2020

Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel

Promega Corporation’s GoTaq Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use.

From Promega Corporation 6 Apr 2020

Australian scientists identify possible coronavirus drug

A collaborative study led by Monash University's Biomedicine Discovery Institute in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.

3 Apr 2020

TGen ramps up testing for COVID-19 to combat global health threat

Since mid-January, the Translational Genomics Research Institute has joined the world-wide effort to test for the SARS-CoV-2 virus causing the COVID-19 disease.

31 Mar 2020

Stellenbosch University and AzarGen Biotechnologies join forces to tackle COVID-19

Stellenbosch University in South Africa and AzarGen Biotechnologies (Pty) Ltd, a South African biotechnology company focused on developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants, have joined forces in the global fight against the coronavirus.

31 Mar 2020

Novel immunotherapy eradicates solid tumors in mice without adverse side effects

Scientists have developed a new immunotherapy that eradicates solid tumors in mice without adverse side effects, according to a new study published today in eLife.

31 Mar 2020

Research shows significant difference in radiation response between sexes

Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia's most experienced radiation oncology medical physicists.

30 Mar 2020

How long to a coronavirus vaccine?

The whole world is waiting for one. A vaccine is the only thing that could conceivably save the world from a horrifying cascade of deaths, other than a miracle, it seems.

29 Mar 2020

Why Primary Cells Are Important for In Vitro ADME-Tox Studies

Lonza is a large, multinational corporation serving the entire pharmaceutical product development and manufacturing pipeline, from non-clinical research products to final dosage and delivery solutions.

From Lonza 26 Mar 2020

Boehringer Ingelheim and Trutino enter into research collaboration to advance cytokine therapies

Boehringer Ingelheim and Trutino Biosciences today announced they have entered into a research collaboration and worldwide licensing agreement based on Trutino’s innovative On-Demand-Cytokine platform.

From Boehringer Ingelheim International GmbH 28 Feb 2020

Already approved drugs may hold the key to treating new coronavirus

The number of people infected with the new corona virus continues to skyrocket, with more than 80000 cases worldwide as of the end of February.

27 Feb 2020

Targeted combinatorial drug treatment restores beta cell function in mice

The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of diabetes.

20 Feb 2020

MD Anderson collaborates with Denali Therapeutics to advance novel therapies for neurodegenerative diseases

The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer's and other neurodegenerative diseases.

20 Feb 2020

The challenge of new antibiotic discovery

It is important to discover antibiotic drugs and to bring them to clinical use, a task made all the more urgent by the increase in the number of infections that are resistant to existing antibiotics. However, this task is a formidable one.

28 Jan 2020

Study could lead to next-generation clinical testing for hidden hearing loss

A pair of biomarkers of brain function -- one that represents "listening effort," and another that measures ability to process rapid changes in frequencies -- may help to explain why a person with normal hearing may struggle to follow conversations in noisy environments, according to a new study led by Massachusetts Eye and Ear researchers.

28 Jan 2020

Expert genomics panel disputes certain genes linked to a dangerous heart condition

A panel of experts have said that nine genes linked to a dangerous heart disorder called long QT syndrome, are not associated with the condition.

27 Jan 2020

Meridian launches High-Specificity Pfu HS Mix to increase customers’ testing capabilities

Meridian Bioscience, Inc. today announced the launch of a High-Specificity Pfu HS Mix that not only provides high-fidelity amplification, but also offers market-leading amplification for companion diagnostic (CDx) and clinical testing.

From Meridian Bioscience, Inc. 24 Jan 2020

Specific group of immune cells may influence Alzheimer’s disease

A new study has revealed that the immune system plays a crucial and previously unidentified role in Alzheimer's disease.

9 Jan 2020

Post-mortem genetic testing used to find underlying cause of sudden deaths in Amish families

Researchers used post-mortem genetic testing to find the underlying cause of multiple sudden deaths in young people and sudden cardiac arrests in two large Amish families.

8 Jan 2020

Dana-Farber Cancer Institute to create Chen-Huang Center for EGFR Mutant Lung Cancers

Dana-Farber Cancer Institute will create the Chen-Huang Center for EGFR (epidermal growth factor receptor) Mutant Lung Cancers to stimulate research, promote clinical trials, and strengthen the Institute's capabilities for studying and treating lung cancer.

7 Jan 2020

Clinical Testing News and Research

Texas A&M chemists focus on searching for drugs to treat COVID-19

Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel

Australian scientists identify possible coronavirus drug

TGen ramps up testing for COVID-19 to combat global health threat

Stellenbosch University and AzarGen Biotechnologies join forces to tackle COVID-19

Novel immunotherapy eradicates solid tumors in mice without adverse side effects

Research shows significant difference in radiation response between sexes

How long to a coronavirus vaccine?

Why Primary Cells Are Important for In Vitro ADME-Tox Studies

Boehringer Ingelheim and Trutino enter into research collaboration to advance cytokine therapies

Already approved drugs may hold the key to treating new coronavirus

Targeted combinatorial drug treatment restores beta cell function in mice

MD Anderson collaborates with Denali Therapeutics to advance novel therapies for neurodegenerative diseases

The challenge of new antibiotic discovery

Study could lead to next-generation clinical testing for hidden hearing loss

Expert genomics panel disputes certain genes linked to a dangerous heart condition

Meridian launches High-Specificity Pfu HS Mix to increase customers’ testing capabilities

Specific group of immune cells may influence Alzheimer’s disease

Post-mortem genetic testing used to find underlying cause of sudden deaths in Amish families

Dana-Farber Cancer Institute to create Chen-Huang Center for EGFR Mutant Lung Cancers

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News